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1. ABSTRACT 
Avian metapneumovirus (aMPV) is an important pathogen that causes respiratory 
diseases and reproductive failure in various avian species. The disease was first 
reported in South Africa in the late 1970s. Later, the disease has been reported 
from all countries around the world, except for Australia, and has caused 
economic losses in poultry industry worldwide due to the transient drop in eggs 
and meat production. In 1998 there was an outbreak in Sweden but due to good 
biosecurity and effective vaccine control program the disease has been under 
control since then. In South America the industry of egg-laying hens struggles 
with many respiratory diseases, such as aMPV, Infectious bronchitis, 
Laryngotracheitis and Newcastle disease. This study is a field project on the 
Avian metapnuemovirus and took place in the state of São Paulo, Brazil. The 
study contributed to a bigger research project at the University of Sao Paulo under 
the department of Preventive Veterinary and Animal Health where the 
veterinarians are trying to control the problems with respiratory diseases in 
Brazilian poultry production. The scope of this study was to detect aMPV in egg-
laying hens with respiratory disease and reproductive failure and further sequence 
the viral RNA and compare it to previously found viral strains. This information is 
important to obtain accurate vaccination-programs for control of the virus. Organ-
samples and blood-samples were collected from five different farms in Bastos, a 
town in the state of São Paulo with extensive egg-production. Reverse 
transcriptase PCR was performed to detect RNA of aMPV in the organs of the 
sampled birds. One out of 66 pools of samples was positive. The sequencing of 
the RNA was unsuccessful and no phylogenetic tree comparing this strain to other 
known viral strains of aMPV could be designed. The blood-samples were tested 
with two types of ELISAs, one indirect ELISA and one blocking ELISA, for 
antibodies against aMPV. Antibodies could be detected in 85 % of the birds with 
the SVANOVIR-kit; and in 87 % of the birds using the IDEXX-kit. A majority of 
the birds had antibody-titers corresponding to previous infection. At the farm 
where the PCR-positive sample was collected, the birds had not seroconverted in 
spite of reported vaccination against aMPV one month earlier. The result of this 
study is consistent with previous conclusions from other studies; that RNA of 
aMPV is difficult to detect and that vaccine prevention of the disease is 
sometimes unsuccessful.  
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2. INTRODUCTION 
With a growing world population, the demand for good-quality livestock products 
is extensive and expected to keep increasing. Brazil is today one of the world’s 
most influential economies but still, approximately 25% of the population in 
Brazil, or about 50 million people live in poverty (ECLAC, 2010). With the 
increasing possibility for better life-standard in many countries, such as Brazil, the 
need for efficient food-production is crucial to meet the demands. Meat from 
poultry serves as an important source of protein and represents almost one-third of 
meat produced and consumed globally (FAOSTAT, 2009). Brazil’s processed 
food exports are showing the fastest rate of growth among the world´s major food 
producers. Brazil is the largest exporter of chicken meat since 2004 and is the 
third producer after the US and China (União Brasilieira de Avicultura, 2012). 
However, infectious diseases represent a true challenge for the industry and 
respiratory diseases in chickens and turkeys can cause enormous economic losses 
for the farmer due to a transient drop in production. Furthermore, diseases also 
cause animal suffering and may contribute to excessive and inappropriate use of 
antibiotics. The prevention of infectious respiratory diseases is crucial and 
research on safe and efficient diagnostic-methods, improvement of vaccines and 
use of vaccines are central issues. Molecular epidemiology is an important part of 
this research and allows a better understanding of diseases from a population point 
of view. This study is a Minor Field Study of the Avian metapneumovirus in the 
state of São Paulo, Brazil as well as a global literature review focusing on 
diagnosis and preventive methods of the disease caused by this virus.  
 
2.1 Scope of the study 
The scope of this study was to isolate and sequence the partial RNA genome from 
field strains of aMPV in chicken from Bastos, Brazil. By designing a phylogenetic 
tree the strains can be compared to other known strains of aMPV in Brazil. 
Another aim was to find out the serological status with regard to aMPV in the 
chickens, and relate this to eventual positive samples and vaccination routines 
within the flock. To determine the serological status, two types of ELISA-tests 
were used and compared.  
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3. LITERATURE REVIEW 
3.1 Background 
3.1.1 History 
In the late 1970s an apparently new and severe respiratory infection in turkeys 
was reported in South Africa (Buys & Du Preez, 1980). In 1989 it was discovered 
in chickens, also in South Africa (Buys & Du Preez, 1989b). The disease, 
characterized by sneezing, tracheal rales, swollen infraorbital sinuses and often 
frothy ocular discharge, was named turkey rhinotracheitis (TRT). This disease had 
a devastating effect on the turkey industry of South Africa and the industry has 
not recovered since (Cook, 2009). In 1986 it was discovered in France (Giraud et 
al, 1986) and then in the UK where the causative agent was isolated (McDougall 
& Cook, 1986) and identified as a pneumovirus (Cavanagh & Barret, 1988). 
Shortly after its appearance in France and England, aMPV was also reported from 
other parts of Europe, the Middle and Far East and Latin America and was soon 
recognized as a major disease threat in both turkeys and chickens all over the 
world (Cook, 2009). In the US, it was reported for the first time the year of 1996 
in turkeys in Colorado and later in Minnesota (Seal, 1998). Serological evidence 
has suggested that aMPV is widespread throughout the world and Australia is the 
only region reported free from aMPV (Gough, 2003 and Lauer, 2001).  
3.1.2 Classification and definitions 
It was the first, and is still, the only avian pneumovirus to have been described 
and is the type strain of a new genus, Metapneumovirus which together with 
another genus Pneumovirus belong to the subfamily Pneumovirinae within the 
family Paramyxoviridae, order Mononegavirales (Lamb et al, 2009). The disease 
caused by avian pneumovirus has been termed TRT, swollen head syndrome 
(SHS) and avian rhinotracheitis (ART), then became known as APV, but is now 
known by the more accurate name, avian metapneumovirus (aMPV) (Cook, 
2009).  
Other known pathogens within the same subfamily are human respiratory 
syncytial virus (hRSV), human metapneumovirus, ovine-, bovine-, and caprine 
respiratory syncytial virus and pneumonia virus of mice (Easton, et al, 2004).  
3.1.3 Serotypes  
There is only one single serotype recognized and four subtypes within that 
serotype; A, B, C and D. The subtypes can be differentiated by molecular 
sequencing and with neutralization tests using monoclonal antibodies (Cook & 
Cavanagh, 2002). The majority of the different subtypes are of the subtypes A and 
B which were reported in Israel (Banet-Noach et al, 2005), Mexico (Decanini et 
al, 1991), Jordan (Roussan et al, 2008), Brazil (Dani et al, 1999 and D’arce et al, 
2005), Japan (Tanaka et al, 1995) and many European countries (Giraurd et at 
1986; McDougall & Cook, 1986; Naylor et al, 1997; Hafez et al, 2000). Subtype 
A is present in South Africa (Cook, 2009). Isolates from USA belongs to subtype 
C (Seal, 1998) and are more related to the human metapneumovirus than to other 
aMPV (Toquin et al, 2003 and Yunus et al, 2003). The fourth subtype D has been 
identified once in Muscovy ducks in France (Bäyon-Auboyer et al 2000). 
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3.1.4 AMPV in Brazil  
The virus was first isolated in 1995, from broiler breeders flocks (Dani et al, 
1999). The first reported virus was a subtype A aMPV and all strains isolated and 
characterized in Brazil up until 2005 belonged to that subtype. In 2007 subtype B 
was detected in Brazilian commercial flocks (Chacón et al, 2007). Subtype A and 
B are to date the only known subtypes circulating in Brazil. A recent study has 
suggested that there could be at least two subtype B subpopulations in Brazil 
(Villarreal et al 2009). Both subtype A and B aMPV are present in wild and 
synanthropic birds in Brazil (Felippe et al, 2011). Further surveillance is crucial 
for knowing which subtypes are currently more prevalent in the field, whether 
alternation between type A and B occurs, and whether the introduction of a 
possible new subtype of aMPV occurs. This data is needed to obtain a good and 
accurate vaccination program in Brazil.   
3.1.5 AMPV in Sweden 
The disease is a part of the national serological surveillance program in Sweden 
and if suspected the veterinarians are obligated to report it. In 1998 there was an 
outbreak of aMPV in parental flocks of meat-producing chicken in southern 
Sweden. Attempts were made to extinguish the disease but the spread continued 
within turkey-breeding companies. Samples were also obtained from a large meat-
turkey farm in the same area and despite having no contact with infected breeding 
flocks, most meat-turkey flocks had high antibody-titers for aMPV but showed no 
clinical symptoms. The virus was detected by RT-PCR but could not be isolated. 
Because the “stamping out” campaign proved unsuccessful, a vaccination-
program was started in Sweden by recommendation from colleagues in other 
countries with experience from the disease. The parental flocks were vaccinated 
with a live attenuated vaccine administrated through drinking water at five to 
eight weeks of age and one inactivated vaccine was given at the age of 18-19 
weeks. A year after the outbreaks the company with milder outbreaks stopped 
vaccinating the parental birds and serological tests have shown that the flocks 
have remained free of the disease since then. The company that experienced the 
worst outbreaks still vaccinates all parental flocks. Both companies still vaccinate 
the grand-parental flocks. The companies with meat-producing turkeys chose not 
to vaccinate the turkeys because the birds had not shown clinical symptoms. One 
year later many of these flocks were still seropositive but none showed clinical 
symptoms (Personal communication with Siamak Zohari, SVA, 2011-11-23). 
3.2 Viral structure composition 
The virus genome is unsegmented and composed of single-stranded negative 
sense RNA of approximately 13.4 kilobases. The genome consists of eight genes 
that encode for viral polypeptides of which two are glycosylated and three are 
non-structural virus-specified proteins. The viral polypeptide have been identified 
as nucleoprotein (N), phosphoprotein (P), matrix protein (M), fusion protein (F), 
second matrix protein (M2), a small hydrophobic protein (SH), surface 
glycoprotein (G), and a viral RNA-dependent RNA polymerase (L) (Gough, 
2003). Figure 1 is a schematic drawing of the genome of aMPV. The pneumovirus 
virion has a lipid envelope derived from the plasma membrane of the host cell into 
which the attachment (G) glycoprotein, fusion (F) and small hydrophobic (SH) are 
inserted. The G-protein mediate attachment to the target cell and the F-protein 
induce fusion between the cell membrane and the virus envelope. The virus 
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nucleoprotein (N), the phosphoprotein (P) and the viral RNA-dependent RNA 
polymerase (L) are associated with the RNA genome and important for its 
replication (Easton, et al, 2004) 
 
Figure 1. A schematic drawing of the order of the aMPV-genome (Easton, et al, 2004) 
 
 
3.3 Susceptibility to chemical and physical agents 
 
The susceptibility of aMPV has been studied using a strain isolated from turkeys 
in Minnesota. The virus remained viable in temperatures at -70 and -20 degrees 
for over 26 weeks, 4 degrees for less than 12 weeks, 20 degrees for less than 4 
weeks, 37 degrees for 48 hours and 50 degrees for less than 6 hours. The virus 
kept its activity for 12 cycles of freezing and thawing. It showed resistance to 
variable pH within the range of 5 to 9 for one hour. Several disinfectants were 
effective in reducing the viability of the virus, including ethanol, sodium 
hypochlorite, iodophos, a phenol derivative and quaternary ammonia. The virus 
showed surprisingly high resistance and could be recovered on cell culture after 
seven days of drying in room temperature. In general though, the virus is 
considered to be quite sensitive (Townsend, et al, 2000). 
3.4 Species susceptible  
Turkeys and chickens are the two most important species susceptible to the 
infection. Serologically the isolates from turkeys and chickens cannot be 
differentiated but biological differences between isolates from the two species 
have been reported and it has been suggested that some turkey isolates do not 
induce respiratory disease in chickens (Cook et al, 1993a). Contrary to this, when 
comparing isolates from chicken and turkeys on genetic level, no species-specific 
sequence exists for aMPV (Clubbe et al, 2009). Serological and molecular tests 
have showed that aMPV can occur in several other avian species. AMPV can 
infect ducks (Toquin et al, 1999), pheasants, guinea fowl (Gough et al, 1988), 
ostriches, Canada geese wild sparrows, geese, swallows and starlings (Njenga et 
al, 2003). 
3.5 Transmission 
Transmission of the virus mostly occurs due to direct contact but the rapid spread 
in many countries is indicating that transmission must occur in other ways as well. 
Indirect spread through transports, equipment, contaminated water and airborne 
spread has been suggested. Although the virus can be detected in the reproductive 
tracts in laying birds, there are no evidence for vertical transmission (Gough, 
2003). The importance of transmission through wild birds has also been discussed 
and might explain the rapid spread of aMPV across the world since the first 
outbreak in South Africa (Cook & Cavanagh, 2002). The US turkey outbreaks of 
APV displayed seasonal pattern with approximately 80% of the outbreaks 
occurring in spring (April to May) and autumn (October to December), suggesting 
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that environmental factors such as migratory birds may be involved in the spread 
of virus. AMPV RNA was isolated from nasal turbinates of geese, wild sparrows, 
starlings and swallow captured in the north central region of the US. The AMPV 
genes were examined and showed high sequence identity with isolates from 
turkeys (90-99 %). In addition, infectious aMPV was isolated from wild Canada 
geese and from sentinel ducks placed in a pond in close proximity with an aMPV 
infected turkey farm. Infectious aMPV has also been isolated from Muscovy 
ducks in France. Although there is evidence that aMPV can replicate in wild 
birds, the role of migratory birds for spread of the virus is still not clear. Canada, 
which neighbors to Minnesota has not reported serious aMPV outbreaks in spite 
of the high incidence of disease in Minnesota (Njenga et al, 2003). In Brazil, both 
subtype A and B are present in wild and synanthropic birds. Differences in both 
nucleotide and amino acid sequence between subtype A of chickens from 
different origins and subtype A from wild avian species suggests that this subtype 
probably has adapted to these birds. The detection of aMPV in wild birds is 
important for the understanding of the epizootology of aMPV in turkeys and 
chicken and, therefore, for the planning of biosecurity measures and vaccination 
protocols for poultry farms (Felippe et al, 2011). 
3.6 Clinical signs, morbidity and mortality 
The clinical signs of aMPV infection are unspecific and characterized by 
respiratory and reproductive symptoms. The same clinical symptoms can be the 
result from infection with other organisms such as Newcastle virus, Avian 
influenza virus, Infectious bronchitis and Avian paramyxovirus type 1. Secondary 
bacterial infections are not uncommon and the characteristic swollen head in SHS 
is usually caused by a secondary infection with Escherichia Coli (Gough, 2003; 
SVA, 2012).  
3.6.1 Turkeys 
AMPV is of great importance in turkeys, where the virus causes a severe 
respiratory infection. In younger turkeys common symptoms can be sneezing, 
nasal and eye discharge, conjunctivitis, submandibular edema, swollen 
infraorbital sinus, snicking and rales. Secondary bacterial infections can 
dramatically increase the clinical signs. Young adults experience coughing and 
head shaking. Morbidity can be as high as 100 %, with mortality ranging from 0.4 
% to 50 %. The disease is also associated with a reproduction failure, which is of 
great importance to farmers breeding turkeys. The decrease in egg production can 
be up to 70 %. The quality of the eggs can be affected with an increased incidence 
of thin-shelled eggs and egg-peritonitis. The severe coughing resulting from a 
lower respiratory tract infection can sometimes lead to prolapses of the uterus in 
breeding turkeys (Gough, 2003 and Cook, 2000). 
3.6.2 Chickens  
In chickens the role of aMPV as a primary pathogen was until quite recently 
questioned and infection may not always be associated with clinical signs. In 
breeders of layers, disease can affect the quality of eggs and cause a range of 
reproductive tract abnormalities, such as egg peritonitis, folded shell membranes 
in the oviduct, misshapen eggs and ovary and oviduct regression. For chicken 
aMPV also plays a role in the complex disease syndrome “Swollen Head 
Syndrome” (SHS) (Villarreal et al 2007). The clinical features of SHS is 
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characterized by swelling of the infra- and periorbital sinuses, torticollis, cerebral 
disorientation, and opistotonus. In figure 2 there is a hen with severe SHS. The 
morbidity for SHS is often less than 4 %, but respiratory signs are often 
widespread in the flock. The mortality is low, usually not more than 2 % (Gough, 
2003). 
 
 
Figure 2: A hen with severe swollen head syndrome. The picture was taken in Bastos, 
Brazil in September 2011 by Clara Atterby. 
 
3.7 Diagnosis 
The nature of aMPV with its genetic and antigenic variation as well as the 
difference in clinical features, require adequate and reliable methods for 
diagnosing infection. There are several methods for diagnosing aMPV. The virus 
can be isolated or detected using electron microscopy, immunochemical 
techniques or molecular techniques such as PCR or serologically by 
demonstrating specific antibody response to the virus (Cook & Cavanagh, 2002). 
3.7.1 Isolation of Avian Metapneumovirus 
Avian metapneumovirus can be very difficult to isolate and the success rate might 
be low. Furthermore, for reasons that are not apparent, virus isolation from 
chickens is more difficult than from turkeys. However, virus isolation is the only 
method of choice if live virus is required for the research. Ideally the virus is 
isolated from nasal secretion and tissue scraped from the sinuses of the affected 
birds. It has also been isolated from trachea, lung and viscera of affected poults. It 
is important to collect the samples from flocks that have not yet obtained severe 
clinical signs as the virus may not be present in sinuses and turbinates for more 
than six days. Secondary bacterial infections can be the cause of the severe 
clinical signs seen later and this can be the reason for the difficulties in isolating 
aMPV from chickens suffering from SHS (Gough, 2003 and Cook & Cavanagh, 
2002).  
For the primary isolation of aMPV from field material from either turkey or 
chicken flocks, the method of choice is either the use of embryonated eggs 
inoculated via the yolk sac or chicken or turkey embryo TOC (trachea organ 
culture). A multiple approach should be applied to the method of isolation since 
experience has showed that different isolates can require different methods for 
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isolation. An example of this is the US isolate of aMPV for which the use of TOC 
has proven inappropriate for primary isolation Once the virus has been isolated 
using one of the two methods, the egg-fluid can be inoculated onto cell cultures 
such as chick embryo fibroblasts (CEF), chick embryo liver (CEL), or VERO 
cultures. A cytopathic effect, characterized by scattered focal areas of cell 
rounding and syncytial formation, is seen after a few passages (Cook & 
Cavanagh, 2002). 
To confirm the identity of the aMPV electron microscopy or immunochemical 
methods can be used. When studied under the negative staining electron 
microscopy the aMPV virus has a highly pleomorphic appearance, the particles 
are enveloped and the sizes range from 80 nm to 500 nm (Gough, 2003). There 
are three immunochemical methods that are used for detecting aMPV in turkeys; 
immunofluorescence (IF), immunoperoxidase (IP) and immunogold staining. For 
detecting aMPV in chickens IF and IP are being used. The value of these tests 
under field conditions has not been fully evaluated, nor have any scientific studies 
been undertaken to compare the sensitivity and specificity of IF and IP (Cook & 
Cavanagh, 2002). 
3.7.2 PCR – Polymerase Chain Reaction and sequencing 
Reverse transcription PCR (RT-PCR) is a more rapid and sensitive method for 
detection of aMPV compared to virus isolation due to its powerful amplification 
technique (Cook & Cavanagh, 2002).  
If the virus is propagated in cell cultures or TOCs (tracheal organ cultures) the 
virus is detected more easily by PCR. However, due to time limitations in 
laboratories, this is not always possible. The samples used for PCR can be tissue 
samples from internal organs such as lungs, ovary, kidney and enteric tract, 
samples from the upper respiratory tract such as nasal and tracheal tissue or swabs 
from nasal, buccal, pharyngeal, tracheal or esophageal tissue. In one study, the 
success rate of detecting aMPV with RT-PCR in tracheal and esophageal swabs 
was compared to the success rate with extracted RNA from nasal and tracheal 
tissue. RNA was detected 5 days post-infection in both materials but the tissue 
contained inhibitory material that needed dissolving which required a higher 
dilution in water while extracting the RNA. Comparative studies between 
detecting viral RNA from wet swabs and dried swabs respectively have been 
performed and showed that both methods are successful. Dried swabs are favored 
as they can be sent to the laboratory by mail without risking overgrowth of other 
microorganisms that might destroy the viral RNA (Cook & Cavanagh, 2002).  
First-round RT-PCR may be sufficient in detecting aMPV and is sometimes 
preferred to nested-PCR because it minimize the possibility and consequences of 
cross-contamination with DNA made during the first PCR. However, first-round 
PCR sometimes fails to detect viral RNA of aMPV whereas nested PCRs detect it. 
Even with nested RT-PCR the detection rate can be low (Cook & Cavanagh, 
2002). Today, a common approach for detection of aMPV by PCR is to amplify 
the G-gene of the genome. For detecting aMPV subtype A and B the primers G6- 
in conjunction with G1+ is being used to prime the RT reaction. The 444 base pair 
product can be used in a nested PCR where the primer G5- is used along with 
G8+A for subtype A and G9+B for subtype B, generating cDNA of 268 and 361 
base pairs, respectively (Cavanagh et al, 1999).  Another approach to detect 
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subtype A and B is to amplify the N-gene of the genome using primers Nd/Nx  
described by Bayon-Auboyer et al. (1999). The primers bind in to a conserved 
area of the N gene and the RT-PCR produce a 115 base pair fragment. The 
positive samples can be further nested to determine which subtype it is using the 
primer Ga in conjunction with G12 for subtype A and G2 for subtype B (Banet-
Noach, 2005).  
 
The fusion (F) protein gene of a subtype A virus was the first gene to be cloned 
and sequenced. Since then, all the genes of the subtype A virus have been 
sequenced (Cook & Cavanagh, 2002). For subtype B, all genes except for the L 
gene have been sequenced.  Sequencing of all genes from subtype C has also been 
reported (Govindarajan et al, 2004). For subtype D, the G protein and parts of the 
F and L proteins, have been sequenced (Bäyon-Auboyer et al, 2000).  
Sequencing have revealed moderate to extensive differences between the four 
currently known subtypes. The F protein of subtype C virus has approximately 72 
% amino acid identity with the F protein of subtypes A and B. Between the A and 
B subtypes the identity of the same gene is 83 % (Seal et al, 2000). For the 
subtype D, the F gene has been compared to the F genes from subgroup A, B and 
C and revealed amino acid identities of 70-97 % (Bäyon-Auboyer et al, 2000). 
There is also diversity within subtypes. A study performed by Naylor et al. (1998) 
compared the F and G protein of subtype B from viruses isolated for a decade 
from several different countries. Both protein showed >98% amino acid identity 
and the conclusion was that very little change had occurred. As mentioned earlier, 
the great majority of aMPVs detected and sequenced have been subtypes A and B, 
with the exception of the US where subtype C is dominating. For subtype D, only 
two isolates have been detected in France. 
If subtype-specific RT-PCR is the only method used for detecting aMPV, eventual 
new subtypes could easily go undetected. Bäyon-Auboyer et al. (1999) suggest 
that a N gene sequence-based RT-PCR for initial detection of aMPV should be 
performed, followed by G gene based subtype-specific RT-PCR in positive 
samples. This was suggested because all the known subtypes up until then (A, B 
and C) had been detected using RT-PCR targeting the N-gene. Subtype D was 
identified by sequencing the G-gene but no oligonucleotide primers used to 
characterize subtype A or B aMPVs were able to amplify the G genes of the 
isolates. The G-gene was amplified by using primers specific for flanking genes 
(Bäyon-Auboyer et al, 2000).  
Even with the sensitive PCR-method, aMPV can be difficult to detect. This can be 
due to a poor replication rate of the virus. Some strains of aMPV always have a 
low rate of replication but factors such as previous vaccination and simultaneous 
infections can also decrease the replication, making it more difficult to detect with 
PCR.  Previous aMPV-vaccination is expected to reduce replication of the virus. 
A simultaneous infection with IBV or IBV-vaccine can interfere with the 
replication on aMPV and therefore decrease the possibility to detect aMPV (Cook 
& Cavanagh, 2002). It can also be difficult to detect RNA from vaccine. 
Compared to IBV where RNA from the IBV vaccine can be detected several 
weeks after vaccination, aMPV RNA vaccine can go completely undetected. 
(Cavanagh et al, 1999).  
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3.7.3 Serology 
Diagnosis of aMPV infection in both turkeys and chickens are usually done 
serologically. ELISA is the most common serological way of diagnosing aMPV 
infection in chicken and turkeys (Cook, 2000). Other serological methods like 
serum neutralization and indirect immunofluorescence can also be used (Cook & 
Cavanagh, 2002). 
3.7.3.1 ELISA 
There are a number of commercial ELISA-kits available, most of them are 
indirect ELISAs but some of them use the method of blocking/competitive 
ELISA. In the indirect method, microtitres plates are first coated with aMPV 
antigen and the test serum is then added, followed by an enzyme-labeled anti-
turkey or anti-chicken conjugate. A substrate/chromophore solution is added and 
the enzyme catalysis of the reaction gives a colored product. AMPV-specific 
antibodies are detected by the color change seen, the color is quantified using a 
spectrophotometer and the enzymatic activity is directly proportional to the 
antibody concentration in the test serum (Cook & Cavanagh, 2002). For blocking 
ELISA the plates are first coated with an aMPV antigen and the test serum is then 
added, followed by enzyme labeled monoclonal antibodies (mabs) targeting 
specific antigen-sites. If the test serum contained aMPV antibodies the binding of 
mabs to the antigen is blocked. By adding a substrate, the result is visualized. 
Thus, the higher the eventual antibody-concentration in the test serum, the weaker 
the signal (Crowther, 2009).   
Although the method is used frequently, there are many reported problems with 
ELISA as a diagnostic method for aMPV. Considerable differences in sensitivity 
in particular but also specificity of different ELISA-kits have been reported (Cook 
& Cavanagh, 2002). When the ELISA-kit fails to detect antibodies this can be due 
to several factors. The type of virus-strain used as antigen in the ELISA has 
proven to be important. A study performed by Eterradossi et al. (1992) showed 
that ELISA-kits with antigen-isolates originating from the same country as the 
antibodies were more successful compared to ELISA-kits where the antigen and 
antibody were from different geographical areas. The same workers also suggest 
that the choice of inadequate antigen for serological testing could hinder the early 
diagnosis of aMPV infection (Eterradossi et al, 1995). It is important to note that 
ELISA tests that detect both subtype A and B might only detect subtype C very 
poorly (Cook et al 1999). Information regarding serological methods for 
diagnosing subtype D is scarce. When comparing the use of indirect ELISA to 
blocking ELISA the blocking ELISA could be appropriate for testing sera from a 
variety of avian species because the test does not rely on conjugate from any 
particular avian species. When deciding what ELISA kit to use, one should 
consider factors that influence the data; the type and source of vaccine used, the 
type and source of the sample, the type of field challenge that might be expected 
and the type of information required from the test. Cook & Cavanagh (2002) 
comment on this: “This suggestion that different kits are suitable for different 
purposes, while justified from the results of that study, is clearly undesirable. The 
objective for performing the test is likely to be to obtain answers to some or all of 
the aforementioned questions, not to assume knowledge of these answers in 
advance.” The conclusion would be that until better kits are available it is 
important to be aware of the weaknesses regarding ELISA.  
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3.8 Methods of controlling the disease 
It quickly became apparent that controlling aMPV infections by means of strict 
hygienic procedures combined with the use of good biosecurity was not adequate. 
Live attenuated and killed vaccines soon became the most important method of 
controlling the disease. Due to the size and high complexity of the poultry 
industry in most areas the disease is impossible to extinguish, although this was 
achieved in Colorado, USA. The reason for the success in Colorado might have 
been the relatively small size and isolated location of the outbreak there, 
combined with England’s expertise concerning the epidemiology of the disease 
(Cook, 2009). Sweden is another area mentioned by Jones (2010) as an example 
of successful eradication of aMPV, probably due to the small chicken population 
in the country combined with careful monitoring and strict attention to 
biosecurity. The maternal immunity in turkeys fails to protect young turkey poults 
from infection (Naylor et al, 1997b).  
 
3.8.1 Vaccination 
For turkeys, effective vaccines were developed and were quickly put into 
production and became widely used. When administered correctly they provide 
excellent protection for turkeys of all ages and are being used for meat turkeys as 
well as layers and breeders. The live attenuated and inactivated vaccines have 
been shown to stimulate both systemic immunity and local immunity in the 
respiratory tract (Gough, 2003).  Vaccination is usually achieved by spray or 
ideally by eye drop, but in the future, the in ovo route might prove to be even 
better (Hess et al, 2004). A single vaccination may be sufficient to protect meat 
turkeys throughout their life but reinfection can occur later in life and meat 
turkeys that are reared beyond 10 to 12 weeks are sometimes revaccinated. A 
typical vaccination program for aMPV in turkeys would be the application of a 
live subtype A or B strain combined at day-old poults using a coarse spray, 
repeated at 7 to 10 days and again at 4 to 6 weeks. The strategy is to produce cell-
mediated immunity in the respiratory tract. Breeding stock would additionally 
receive an inactivated vaccine at 16 to 20 weeks (Gough, 2003).  
However, failure of the vaccine is not uncommon and can be due to several 
factors such as over attenuation of the virus strains leading to a weak immune 
response, under attenuation leading to severe reaction or poor vaccine 
administration (Cook, 2009). There are many reports of post vaccinal disease and 
one underlying reason could be instability of the vaccine (Catelli et al, 2006). In 
experimental conditions, disease has been seen after 4-10 back passages of 
vaccine in naive turkeys (Naylor & Jones, 1994). In a field study from a turkey 
farm in Italy it was shown that respiratory disease was caused by a virus 
originating from a live subtype A vaccine. Particularly interesting was the fact 
that this flock had not received vaccine for subtype A indicating that aMPV 
vaccines are able to circulate in the environment for longer than was previously 
envisaged (Riccizzi et al, 2009). Failure of the vaccine could be due to the 
involvement of several or unexpected subtypes. Though there is evidence for 
excellent cross protection between A and B subtypes vaccine (Eterradossi, 1995) 
as well as cross protection to subtype C with both A and B subtypes vaccines in 
turkeys (Cook et al, 1999) there are also studies that in contradiction to this 
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confirms limited cross-protection between subtypes (Riccizzi et al, 2009; Van de 
Zande et al, 2000). Another aspect that has been considered as a factor regarding 
poor vaccine-results is the interference between other pathogens and the vaccine. 
A field study performed in Brazil by Cardoso et al. (2009) investigated the 
possibility of low aMPV vaccine performance due to interference by a persistent 
infection with turkey astrovirus and concluded that this might be possible. Yet 
another factor could be the ability of the virus to mutate quickly and the 
possibility that this might allow the virus to avoid an immune response induced by 
vaccination. This was examined by Catelli et al. (2009) where turkey-poults were 
experimentally infected with the more recent subtype B Italian isolates after 
vaccination with the common subtype B vaccine, which has the earlier virus 
sequence. The result of the study was that a majority of the vaccinated birds who 
were challenged with the “new” subtype B isolate showed severe clinical 
symptoms and the conclusion was that the field virus had changed in key 
antigenic regions in order to thrive within a group of well vaccinated birds. 
Despite these possible problems, vaccination continues to be seen as highly 
beneficial, provided careful attention is paid to the method of administration 
(Cook, 2009). 
 
For chickens, the difficulties involving the diagnosis of aMPV, have led to doubts 
on whether the vaccines are in fact effective. For broilers in particular there are 
many reports on the failure to control disease for aMPV-vaccines. According to 
Cook (2009) good diagnosis is essential in order to evaluate the efficacy of the 
vaccine since aMPV vaccines will not improve the situation in a flock where 
aMPV is not present.  
It has been hypothesized that aMPV vaccines will be more efficacious in the 
species from which the progenitor virus was derived because of antigenical 
differences; however protection studies have proven difficult. A study performed 
by Clubbe et al. (2009) compared chicken and turkey derived aMPV subtype B at 
their underlying genetic level to identify if species-specific regions exist. While 
numerous sequence differences between viruses were identified, none was 
specific for the host species. However, because of the possibility that isolates from 
chickens may replicate more efficiently in that species, the perceived advantage of 
using chicken-origin strains led to development of vaccines incorporating strains 
of aMPV isolated from chickens for use in that species (Cook, 2009).  
Further, there is a risk of interference between aMPV and IB- or NDV-vaccines 
since these viruses target the same cells in the respiratory tract. It is therefore 
advisable to consider leaving an interval of approximately one week between 
vaccination against IB and ND and administration of aMPV vaccine (Cook, 
2009). 
3.8.2 Protection of egg-laying and breeding birds 
For egg-laying birds, in addition to the live attenuated vaccines, effective 
inactivated aMPV vaccines are widely used. It has been shown both 
experimentally and under field conditions that the use of inactivated vaccines can 
provide good protection against the effect of aMPV challenge on egg production 
and egg quality, although some clinical signs may be seen for a short time after 
challenge. Therefore, in some countries where it is difficult to license live-
attenuated aMPV vaccine, control programs including inactivated vaccines are 
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being used (Cook, 2009). In a study performed by Villarreal et al. (2009) in an 
aMPV-endemic region of Brazil, comparison was made between three flocks with 
egg-laying hens that had received aMPV vaccines with two control flocks, also 
with egg-laying hens, that had not received vaccines for aMPV. Both groups had 
received vaccination against IBV, NDV and EDSV. Control flocks showed 
characteristic symptoms of aMPV whereas the vaccinated flocks showed no 
clinical symptoms. 
3.8.3 Biosecurity 
Good biosecurity is crucial for commercial poultry and egg production and the 
severity of aMPV infection is significantly depending on management factors. In 
terms of biosecurity there are many factors to consider, such as high stocking 
density, insufficient ventilation and temperature control, poor litter quality, 
general hygiene, multi-age stock and the presence of secondary pathogens 
(Gough, 2003). Biosecurity in poultry production is very important but complex 
and will not be further discussed in this literature review. 
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4 MATERIALS AND METHOD  
 
4.4 Site of sample collection 
Sample-collection took place in Bastos, a town in the state of São Paulo, Brazil. 
See figure 3. 
  
Figure 3:  
Map of Brazil    Map of the state of Sao Paulo  
 www.sao-paulo.world-guides.com               www.mapzones.com.  
   Bastos is situated near the star on the map. 
                            
 
                                                                                       
Bastos is well-known in Brazil as one of the most important regions for poultry-
production. The town is small with about 20.000 inhabitants but the number of 
birds is great with 15 million layers of hens, as well as four million quails. There 
are approximately 200 different poultry-farms in Bastos and the farms are located 
very near each other which in addition to the very low biosecurity are the reason 
to why the town of Bastos almost can be considered one extremely large flock in 
terms of disease-control.  Given the very high avian population density in the area 
it is not hard to understand that the infectious diseases are likely to spread easily 
and infect and re-infect flocks repeatedly. Some of the circulating pathogens in 
Bastos include Infectious Bronchitis virus, Mycoplasma spp, Laryngiotracheitis, 
Avian metapneumovirus and Newcastle virus. The routine for disease-control is 
mainly vaccines, although this strategy has shown varied results. Biosecurity is as 
compared to high international standards very poor. Figure 4 is a photograph 
demonstrating the poor biosecurity in Bastos. For most farms there are no routines 
for visitors in terms of change of clothes and shoes, no restriction for inter-farms 
visiting per day, very high population density, no physical barriers (i.e. walls) 
between the flocks and wild birds with highly dirty facilities that enables airborne 
pathogens to easily transmit from one flock/farm to another. Respiratory diseases 
are very common and decrease in production is often a symptom to such 
problems: respiratory diseases are often associated with huge economical loss to 
the farmer. Though, instead of improving biosecurity and vaccine-routines to 
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better control the disease-situation the farmers are applying a buffer-method with 
high quantity of birds, where some flocks are sick while others are healthy and 
well-producing. The situation in Bastos makes the area well-suited for 
epidemiological virology studies and extensive research regarding many 
infectious diseases in Bastos are ongoing at the Department of Preventive 
Veterinary Medicine and Animal Health College of Veterinary Medicine, 
University of Sao Paulo (Own observations and interview with Laura Villarreal 
and Prof. Paulo Eduardo Brandão). 
 
Figure 4. A typical farm in Bastos, Brazil. The houses are designed without walls and the 
flocks are situated near each other and near outside vegetation and wild birds. The 
picture was taken in Bastos, Brazil in September 2011 by Clara Atterby. 
 
4.5 Sample collection 
For three days in September, blood and organs samples were collected from 
commercial layer hens in Bastos. The farms and flocks were selected based on 
several factors; owners willingness, presence of respiratory disease, other 
practical issues and most importantly previously performed epidemiological 
studies at the chosen site. Our results were used as complementary information to 
a larger scale research on epidemiological studies on, amongst other viruses, 
aMPV in chickens and quails in Bastos. Blood-samples were obtained in 14 flocks 
within five farms and from 13 of these flocks within four farms organ-samples 
were also obtained. The amount of birds from which blood was sampled ranged 
from five to twenty per flock with a total of 182 samples. The amount of blood-
samples collected were not pre-planned in detail and depended on accessibility to 
collection-material, willingness of the owner and other practical factors. About 
three milliliters of blood was collected from the vein on the inside of the wing, 
vena cutanea ulnaris, and then transferred to a new tube. The blood was stored 
cool and serum was separated from the blood within 24 hours by centrifugation. 
Out of the 182 samples, 159 could be used for analyzing, the others were 
discarded due to small volume resulting in inability to obtain sufficient amount of 
sera. The amount of birds from which organ-samples (trachea, lungs, kidneys, 
reproductive tract and enteric content from mostly caecum) were obtained was 
five per flock, with the exception of one flock where six birds were collected 
resulting in a total of 66 birds. The samples were pooled specifically for each 
organ for every flock resulting in pools of five (six in one) birds per pool and five 
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pools per flock resulting in 65 pools of samples. The amount of birds per pool is 
standard for this kind of research at USP. The birds were euthanized by 
dislocation of the neck and afterwards dissected either immediately at site or 
within three hours at the local veterinary clinic. The organs were stored frozen. 
See figure 5 for photographs from the sample-collection. The birds chosen for 
blood-samples and organ-samples showed varied degree of respiratory symptoms 
where some birds showed none but most showed some respiratory symptoms and 
several had severe symptoms with nasal and eye discharge and dyspnea. At least 
one of the birds had developed “swollen head syndrome” with heavy swelling of 
the infra- and periorbital sinuses. For detecting aMPV it is optimal to collect 
samples from birds that have not yet started to show severe clinical symptoms, 
ideally a neighboring flock to one with clinical symptoms. However, it was 
difficult to explain this in a convincing way to the present veterinarians and 
owners and therefore most of the birds that were sampled had already developed 
clinical symptoms. A few birds showed pathological findings when dissected like 
liverlipidoses, pneumonia, ovarian cysts and hepatosis. Due to practical 
difficulties in the field it was unfortunately not possible to obtain reliable data for 
the presence of clinical symptoms or pathological findings and relate this to the 
samples and result. All of the farms were asked to send a copy of their 
vaccination-program but unfortunately only two did. According to the 
vaccination-program, one of the two farms vaccinated the birds for aMPV by 
ocular administration (PNEUMO RTV 8544 from Intervet) at the age of 14 and 
71 days. The birds were also vaccinated for Infectious laryngotracheitis, Bursal 
disease, Infectious bronchitis, Mycoplasma gallisepticum, Avian 
Encephalomyelitis, fowl pox, Infectious coryza and Salmonella enteritidis. The 
other farm did not vaccinate for aMPV but vaccinated for Infectious 
laryngotracheitis, Bursal disease, Infectious bronchitis, Mycoplasma 
gallisepticum, Infectious coryza and Newcastle disease. The third farm did not 
send their vaccination-program but the farm-veterinarian stated that they do not 
vaccinate for aMPV. The vaccination-program for the other two farms was 
unknown. The birds were of different breeds; Hisex, Isa Brown, Dekalb brown 
and Bovan. From two farms, the breeds of the birds were unknown. The age of the 
birds ranged from approximately 18 weeks to 77 weeks. For three of the farms, 
the age is unknown. All of the birds were housed in cages, the number of birds per 
cage was 2-8. The exact size of the cages was unknown but varied amongst flocks 
and farms. All of the bird-houses had low biosecurity and were designed without 
doors, most houses also lacked walls. The flocks were situated very near each 
other, the closest distance observed was six meters. 
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Figure 5:  
Blood-sample from the vena cutanea            Clara Atterby dissecting a hen at a farm in 
ulnaris of a hen in Bastos, Brazil.                 Bastos, Brazil.  
 
Both pictures were taken in September 2011 by Caroline Olofsson. 
 
4.6 Laboratory techniques  
4.6.1 RNA-extraction and PCR 
Pools were prepared by mechanical decomposition of the organs and 1:2 diluted 
(v/v) with diethyl pyro carbonate (DEPC)-treated water and submitted to three 
freeze-thaw cycles and clarified by centrifugation at 5000 x g for 15 minutes at 
4°C. For every five samples, one negative control was prepared and for each test 
run subtype A aMPV vaccine was used as the positive control. The total RNA of 
field and vaccine samples and negative controls was extracted with TRIzol 
reagent (Invitrogen
TM) according to manufacturer’s instructions. 3.5 µl of total 
extracted RNA were denatured at 94°C for 5 minutes and added to the reverse 
transcription mix containing 1xFirst Strand Buffer, 1mM dNTP, 10mM DTT 
(dithiothreitol), DEPC-water, 2,5ng random primer and 100 U of the enzyme M-
MLV (Maloney murine leukemic virus) reverse transcriptase (Invitrogen
TM
) to a 
final reaction volume of 6,5 µl. Reverse transcription was carried out at 37°C for 
60 minutes, followed by 10 minutes at 72°C. The reaction creates cDNA from all 
the available RNA templates. 2,5 µl of cDNA per sample were amplified by PCR 
in a mix containing 10 x PCR Buffer (Invitrogen
TM
), 0,625 U Taq DNA 
polymerase (Invitrogen
TM
), dNTP, 1,5 mM magnesium chloride, DEPC-water and 
0,5 µM of each primer (G6- and G1+) to a final reaction volume of 25 µl. The 
conditions for DNA amplification were 94°C/3 min for initial denaturation, 
followed by 30 cycles of 94°C/1 min, 50°C/1.5 min and 72°C/2 min and a final 
extension at 72°C/10 min. The nested step was performed by adding 2.5 µl of the 
first round PCR product to a similar mix containing other primers (G5-, G8+A 
and G9+B) to a final reaction volume of 25 µl. Primers and reaction conditions 
used was described by Cavanagh et al. (1999) and Juhasz and Easton (1994), to 
amplify 268 base pair (bp) or 361 bp fragments corresponding to subtypes A and 
B, respectively, of the aMPV G-gene. Specific rooms with restricted equipment 
were used for each step (sample preparation and RNA extraction, reverse 
transcriptase, and first-round amplifications and second-round amplifications 
followed by electrophoresis). Next, 10 µl nested-PCR product were visualized 
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after electrophoresis in a 1.5 % agarose gel that was stained with ethidium 
bromide (0,5 µl/ml). The nested PCR product from the positive sample (268 bp) 
corresponding to the G glycoprotein from aMPV, a negative control (DEPC-
water) and the vaccine sample was amplified to a total volume of 45 µl. The total 
volume was applied to a slow electrophoresis in a 1.5 % thick agarose gel which 
was stained with ethidium bromide (0,5 µl/ml).   
4.7 Sequencing and phylogenetic analysis  
Using a clean scalpel and wavelength (365 nm) ultraviolet light and minimal 
exposure time, the band containing the PCR product sample of interest was cut 
out and put into a DNAse-free micro centrifuge tube. The sample was purified 
using the GFX PCR DNA and Gel Band Purification Kit (from GE Healthcare). 
First 800 µl Capture buffer type 3 was added to the sample to denature proteins 
and dissolve agarose. The mix was then applied to the GFX Micro Spin Column 
and Collection tube where DNA can bind to the membrane. The tube was 
centrifuged and the flow was discarded. After this, two steps of washing and 
drying was performed by adding 500 µl Wash buffer type 1 to the GFX Micro 
Spin column, then spin the tube and discard the collection tube to remove salts 
and other contaminants from the membrane bound DNA. The GFX Micro Spin 
column was transferred to a fresh DNase-free 1.5 ml micro centrifuge tube. The 
last step was to elute the purified sample from the column with 50 µl Elution 
buffer type 6 (nuclease free water). The tube was spinned to recover the purified 
DNA, the column was removed and the Collection tube was stored frozen at -20 
°C. The RT-PCR products were sequenced in both the forward and reverse 
direction. First, the purification products was added to a mix and then submitted 
to another thermocykle-program; 35 cycles of 96ºC/30 sec, 50ºC/15 sec and  
60ºC/4 min, with a ramp of 0.7ºC/seg between each temperature. The mix 
contained 4 µl Big Dye 301, 4 µl Segmented buffer, 0,4 µl primer, G1+ for 
forward and G5- for reverse, and 11,6 µl sample to a final reaction of 20 µl. DNA 
sequencing was performed using ABI 3500 to confirm the specificity of the 
amplicon. All possible sizes of fragments were marked with a nucleotide-specific 
fluorescent light and detected using a laser.  
A phylogenetic tree could not be constructed because the DNA sequencing  
was unsuccessful. The purpose of the tree would have been to  
evaluate the relatedness between the detected viral strains to other 
known strains of aMPV. The sequence was analyzed using a program called Mega 
5 that design a phylogenetic tree based on  
sequence similarity to all other DNA-sequences within a large global database. 
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Figure 6: Professor Paulo Eduardo Brandão is supervising at the lab of University of 
Sao Paulo, department of Preventive Veterinary and Animal Health  
 
4.8 ELISA-test  
For detection of eventual antibodies in collected blood from 159 birds, the serum 
was analyzed at the lab using the SVANOVIR Avian Pneumovirus - Ab ELISA 
kit. 62 samples of the same serum were also sent to another lab where the IDEXX 
Avian Pneumovirus – Ab ELISA kit was used. The results of the tests were then 
compared.  
The SVANOVIR kit procedure is based on the Blocking-ELISA (Blocking 
Enzyme Linked Immunosorbent Assay). The samples were added to a microtitre 
plate coated with aMPV antigen. If aMPV-antibodies are present they will bind to 
the antigen in the well and block these antigen sites. If there are no aMPV-
antibodies present, these sites will remain free. Horseradish peroxidase (HRP) 
conjugated monoclonal antibodies directed to aMPV are added and they will bind 
to the sites if they are available. In that case, when the substrate is added, a blue 
color develops marking that the sample is negative. If the sites are occupied by 
aMPV-antibodies from the sample, the conjugate are unable to bind and will be 
washed away before the substrate is added resulting in no color which means that 
the sample is positive. The result was clear and visible to the eye but a microplate 
photometer was used to measure the optical density (OD) at 450 nm. OD readings 
from the samples were used to calculate the percent inhibition (PI) by this 
mathematical formula: (OD Neg control – OD positive control/sample)/OD Neg 
control x 100. For positive result the PI is <40, for negative result the PI is >30, 
samples with a PI of 30-40 are considered doubtful. 
 
IDEXX-kit – 62 selected samples were sent to another lab specialized in 
analyzing blood-samples with the Idexx-kit. The reason for not sending all 
samples was the unexpected high cost. The choice was made to include serum 
from all collected flocks. Samples that were considered doubtful on the Svanovir-
kit were selective chosen. The IDEXX-kit is based on an indirect ELISA and can, 
according to the manufacturer also analyze the quantitative titer of the antibodies. 
 
25 
 
5 RESULTS  
5.1 AMPV detection by RT-PCR  
One out of 65 organ pools was positive for aMPV. The positive sample was 
aMPV subtype A and the RT-nested PCR technique amplified the 268 bp 
fragment of the G-gene (Figure 7). The positive sample was found in flock 42 in 
pools of trachea. This flock was approximately 18 weeks old and had been 
vaccinated against aMPV one month prior to the sampling. In the other 65 pools 
of organs, no aMPV could be detected and amplified with RT-PCR. 
     M        1        2        3        M 
 
Figure 7. RT-PCR of Brazilian strain of aMPV. Lane 1 subtype A field strain; 
lane 2, negative control; lane 3 subtype A vaccine strain, M, molecular size 
marker (100 bp ladder) Picture taken by Clara Atterby, 2011-10-14 at 
University of Sao Paulo, lab of VPS.  
 
5.2 Sequencing and phylogenetic analysis 
The sequencing was unsuccessful and could not be used for phylogenetic analysis. 
5.3  AMPV-antibodies detection by two different ELISA-kits  
SVANOVIR Avian Pneumovirus – Ab ELISA kit; 135 out of 159 (85%) samples 
of sera were positive for aMPV, 18 out of 159 (11%) were negative and 6 out of 
159 (4%) were considered doubtful.  
IDEXX Avian Pneumovirus Ab ELISA kit; 59 out of 62 (87 %) samples of sera 
were positive for aMPV, while 3 of 62 (13 %) were negative. Since the purpose 
was to include samples for analyze with the IDEXX-kit that were considered 
doubtful on the SVANOVIR-kit the samples were not randomly selected. 
Therefore it would be inappropriate to compare the percentage of positive and 
negative results between the two tests, although it is obvious that the results are 
similar. However, on the individual level, the results of the two tests were 
compared and all samples that were positive with the SVANOVIR-kit were also 
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positive with the IDEXX, and the same applies to the negative results. Four 
samples were considered doubtful on the SVANOVIR-kit; two of these were 
positive and two were negative with the IDEXX-kit.  
According to the manufacturer, the IDEXX-kit is able to differentiate antibody-
titers corresponding to vaccination from titers corresponding to previous infection. 
The base-line is derived from serological control of vaccination-programs in 
Brazil but is not specific for Bastos and the base-lines must be considered to be 
quite general. 78-91 % of the positive serum-samples had titers corresponding to 
previous infection, the remaining had titers corresponding to vaccination. It is not 
possible to achieve a more precise number because of the lack of information 
regarding the age of the sampled birds (e.g. the number of vaccine-doses 
received), which influences the titer corresponding to vaccination.  
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6 DISCUSSION  
One out of 66 organ-samples was positive for aMPV with RT-PCR. The 
occurrence of aMPV in Bastos is however higher than what this result indicates. 
The results from the ELISA-test show that aMPV is in fact circulating/or has been 
circulating in the sampled flocks. Antibodies were found in the majority of the 
birds, also in flocks that had not been vaccinated. It is very difficult to detect 
aMPV, especially in older birds that have developed an immunoresponse after 
previous exposure to the virus. Factors that might explain the low rate of detected 
aMPV could be either suboptimal population for sampling or choice of method at 
the laboratory regarding PCR-type and primers. 
The farms that were sampled all had several flocks with clinical respiratory 
symptoms. AMPV is a probable pathogen causing disease in these flocks but the 
symptoms could also be due to other respiratory diseases such as IB, NDV, ILT 
and Mycoplasma. As described earlier in this paper, for PCR, it is favorable to 
collect samples from birds that have not yet displayed clinical symptoms since 
aMPV is replicating most rapidly in the phase of incubation (Gough, 2003). The 
positive sample was in fact collected from the one flock in the farm that was 
without clinical symptoms. The challenge in choosing the right flock to collect 
samples from is to convince the owner that it is more profitable to collect from the 
flock without clinical symptoms than the neighboring sick flock. To make the 
owner more willing, samples could be collected using swabs instead of organs and 
thereby without killing the birds. 
The sampled material was handled correctly under the given circumstances and 
stored frozen throughout the whole process from the time of sampling to the lab. 
Many samples were positive for other viruses such as IBV and Herpesvirus from 
which the same RNA-extraction was used and therefore it can be assumed that the 
RNA-extraction product was correct. The reverse transcriptase-PCR reaction was 
used which is a good qualitative method for sequencing RNA-viral strains. 
However, the real time-PCR is a quantitative method that is more sensitive in 
detecting positive samples and therefore more useful in studies of prevalence. The 
desired part of the genome for sequencing was the G-gene by using primers 
specified to amplify the gene from subtypes A and B. This is a common approach 
for sequencing aMPV in Brazil where subtype A and B are present. Neither 
subtype C nor subtype D will be detected with this method and in the future it is 
advisable to use a broader technique, a so-called pan-aMPV RT-PCR assay, while 
screening for aMPV or else newly introduced subtypes could go undetected. 
Bäyon-Auboyer et al. (1999) suggest that an N gene sequence-based RT-PCR for 
initial detection of aMPV should be performed, followed by a G gene based 
subtype-specific RT-PCR in positive samples. This was suggested because all of 
the known subtypes up until then (A, B and C) had been detected using RT-PCR 
targeting the N-gene. Subtype D was identified by sequencing the G-gene by 
using primers specific for flanking genes, no primers used to characterize subtype 
A or B aMPVs were able to amplify the G genes of the isolates (Bäyon-Auboyer 
et al, 2000). 
As can be seen in figure 7, p.25, where the electrophoresis of the positive sample 
is displayed, the positive control is very faint or even invisible. The positive 
control failed to work several times during the laboratory work and this is highly 
undesirable. In this scenario it is impossible to know if the assay per se did not 
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work, or that the sample contained aMPV RNA. The positive sample was 
amplified again by another researcher and this time the positive control worked.  
The DNA-sequencing was unfortunately unsuccessful. According to supervising 
Professor Paulo E Brandão the most common reason for this would be an 
insufficient amount of amplified cDNA. Attempts to repeat this will be made. 
The comparison between the two ELISA-kits was not made to a full extent since 
only 62 out of 158 samples were tested using the indirect method of ELISA 
(IDEXX-kit). The SVANOVIR-kit can detect aMPV subtype A and B while the 
IDEXX-kit can detect subtype A, B and C and theoretically, a way to detect 
subtype C could be through comparison between the two tests (Personal 
communication Siamak Zohari, SVA, 2012-02-20). However, the results on all 
tested samples corresponded fully on both tests. Traditionally, the indirect ELISA 
is the method of choice for aMPV but blocking ELISAs are also common 
nowadays. The sensitivity is generally higher for indirect ELISA compared to 
blocking ELISA but the SVANOVIR-kit has according to the manufacturer 98% 
sensitivity in comparison with other ELISAs. To distinguish antibody-titer 
corresponding to vaccination from titer corresponding to infection, the PI-value 
from blocking ELISA can be used but the indirect ELISA is generally more 
precise in determine the titer and would therefore be recommended for serological 
control of flocks after vaccination. The antibody-titers results from the Idexx-kit 
were in this study compared to a general base-line in Brazil. The results would 
have been more certain if each sampled flock had had a base-line derived from 
serological control of the vaccination-titer.  
 
The role for aMPV as a primary pathogen in chickens was recently fully 
established. Gough (2003) writes that aMPV is a very important primary pathogen 
for turkeys but not for chicken. For chicken, aMPV was established as one of the 
pathogens in the multi-systemic “swollen head syndrome”. Nowadays it is widely 
accepted that aMPV can cause respiratory and reproductive disease as well as a 
production decrease in chicken also when the infection is not complicated by 
other pathogens. However, it appears that this new approach within the world of 
research is far from established out on the field. A field-veterinarian in Bastos 
working with chicken stated that he did not believe that aMPV was a primary 
pathogen for chicken and therefore he did not recommend his clients to vaccinate 
the flocks for aMPV. 
The idea that aMPV is not a field-problem could be due to the fact that aMPV-
infection is not always associated with disease, and also because of the difficulties 
involved in the diagnosis aMPV as the causative agent. It is, as described in more 
detail earlier in this paper, hard to isolate and/or detect the virus with PCR, 
especially when the samples are obtained from birds which already have 
developed clinical symptoms. It is not hard to understand that farmers (and 
veterinarians) doubt the fact that aMPV causes disease in chicken when the virus 
is not detected in sick birds.  
There are reports of vaccine breaks and vaccine strains evolving into viral-strains 
for aMPV which probably contribute to the farmers´ apprehension concerning 
vaccination against the disease. In this study the flock with the positive sample 
had not seroconverted according to both tested ELISA-kits despite the fact that the 
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flock had been vaccinated against aMPV one month prior to the time of sampling. 
The birds were 18 weeks old and had received one dose of vaccine. In one month 
the birds should have seroconverted. The lack of immune-response could be due 
to incorrect administration or malfunctioning vaccine.  
At some farms from which sample-collection was performed, the farm-
veterinarian was asked about the use of antibiotics. The veterinarians were not 
keen on discussing the subject but one of them said that the birds are treated with 
antibiotics when they experience respiratory symptoms but the veterinarian could 
not (or would not) give more detailed information. When asked which antibiotics 
they used he said enrofloxacin amongst others.  
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7. CONCLUSIONS 
The results of this study are consistent with previous conclusion from other 
studies; that RNA of aMPV is difficult to detect and that vaccine prevention of the 
disease is sometimes unsuccessful. Further surveillance is crucial for knowing 
which subtypes are currently more prevalent in the field, whether alternation 
between type A and B occurs, and whether the introduction of a possible new 
subtype of aMPV occurs. This data is needed to obtain a good and accurate 
vaccination program in Brazil.  There was no noticeable difference in the results 
of the two tested ELISA-kits. Further evaluation and development of serological 
tests are needed since correct diagnostic methods are crucial in controlling the 
disease. Regarding the use of antibiotics; if the birds are treated with antibiotics 
every time they are sick one could assume that large quantities of antibiotics are 
being used within the Brazilian egg-laying industry and that attempts to treat 
viral-infections with antibiotics are common. Further research within the area of 
antibiotic-use in Brazilian poultry would be interesting and also very important. 
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